Dec 19, 2018 / 22:56
Vietnam to launch 5-in-1 ComBE Five vaccine nationwide late December
ComBE Five is a “five-in-one” vaccine that can help fight against five potentially fatal diseases affecting infants - diphtheria, tetanus, whooping cough, hepatitis B and Haemophilus influenza type B.
ComBE Five vaccine will be launched nationwide to replace Quinvaxem from late December after being tested in seven provinces, the Vietnamese Ministry of Health announced on December 18.
According to the ministry’s report, ComBE Five obtained a license from the Ministry of Health in May 2017 and since October this year, the vaccine has been administered to more than 17,356 children aged 2 – 4 months in the provinces of Ha Nam, Ba Ria Vung Tau, Bac Giang, Binh Dinh, Yen Bai, Kon Tum, and Dong Thap.
The ComBE Five vaccine was developed in a safe manner. The children were closely monitored in three days after immunization. About 5.5% of the children had minor side effects while three babies had severe reactions, including high temperature, seizures and trouble breathing, according to local reports.
The conversion of DPT-VGB-Hib vaccine (ComBE Five) in seven provinces has been approved by the community. There is no refusal to vaccinate.
Produced by Indian vaccine manufacturer Biological E. Ltd., ComBE Five is a “five-in-one” vaccine that can help fight against five potentially fatal diseases affecting infants - diphtheria, tetanus, whooping cough, hepatitis B and Haemophilus influenza type B.
ComBE Five has received the World Health Organization’s pre-qualification approval and more than 400 million doses of the vaccine have been administered to children in 43 countries and territories.
The ComBE Five vaccine
|
The ComBE Five vaccine was developed in a safe manner. The children were closely monitored in three days after immunization. About 5.5% of the children had minor side effects while three babies had severe reactions, including high temperature, seizures and trouble breathing, according to local reports.
The conversion of DPT-VGB-Hib vaccine (ComBE Five) in seven provinces has been approved by the community. There is no refusal to vaccinate.
Produced by Indian vaccine manufacturer Biological E. Ltd., ComBE Five is a “five-in-one” vaccine that can help fight against five potentially fatal diseases affecting infants - diphtheria, tetanus, whooping cough, hepatitis B and Haemophilus influenza type B.
ComBE Five has received the World Health Organization’s pre-qualification approval and more than 400 million doses of the vaccine have been administered to children in 43 countries and territories.
Other News
- Applying digital transformation to foster reading culture
- "Denmark in Your Eyes Contest: Youth networking for a green future
- National language celebrated by Vietnamese community in South Korea
- Hanoi accelerating efforts to reduce new tuberculosis cases
- Hanoi tackles overcrowded classrooms
- Vietnamese journalists get expertise from Indian experts
- Effective STEM education in Hanoi schools
- Vietnamese students' skills recognized in PISA survey
- Hanoi aims for 94.5% health insurance coverage this year.
- Denmark helps Vietnam enhance primary health care
Trending
-
Vietnam celebrates Hung Kings Commemoration Day
-
Vietnam news in brief - April 18
-
Vietnam win first match of Asian U23 tournament
-
Colorful stage shows in Hoan Kiem Lake pedestrian area
-
It happened as it had to happen
-
Hanoi street where dead appliances come back to life
-
Vietnam’s economy urged to rely on internal strengths to weather global uncertainties: ADB
-
Vietnam, Thailand advance realization of “Three Connections” strategy
-
MICHELIN Guide sets its sights on Vietnam’s central region